
T2 Biosystems TTOO
Quarterly report 2024-Q3
added 11-14-2024
T2 Biosystems PEG Ratio 2011-2026 | TTOO
Annual PEG Ratio T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000062 | -0 | -0.000029 | -0.0898 | 0.238 | -0.0767 | -0.317 | -0.576 | -0.0859 | 0.0349 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.238 | -0.576 | -0.0872 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Brainsway Ltd.
BWAY
|
-0.319 | $ 13.69 | 0.29 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 25.72 | -0.43 % | $ 714 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
1.12 | $ 67.65 | 1.97 % | $ 26.4 B | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 153.73 | 1.16 % | $ 7.62 B | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 17.51 | 1.1 % | $ 933 M | ||
|
Guardant Health
GH
|
-3.43 | $ 88.71 | 1.75 % | $ 11.1 B | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | $ 103.89 | 0.04 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 15.47 | 3.48 % | $ 468 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
1.09 | $ 16.58 | -4.11 % | $ 2.15 B | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 99.84 | 2.28 % | $ 8.24 B | ||
|
Anixa Biosciences
ANIX
|
-0 | $ 2.89 | 1.76 % | $ 93.8 K | ||
|
IQVIA Holdings
IQV
|
1.57 | $ 168.66 | 2.34 % | $ 29 B | ||
|
Danaher Corporation
DHR
|
210 | $ 194.7 | 1.73 % | $ 139 B | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
2.16 | $ 121.25 | 1.65 % | $ 19.3 B | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 198.2 | -0.38 % | $ 22 B | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
2.05 | $ 113.1 | 1.14 % | $ 34.4 B | ||
|
BioNano Genomics
BNGO
|
-0.000017 | $ 1.12 | 0.9 % | $ 1.42 M | ||
|
DarioHealth Corp.
DRIO
|
0.0333 | $ 9.0 | 6.89 % | $ 255 M | ||
|
NeoGenomics
NEO
|
0.0904 | $ 8.26 | 0.18 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 9.24 | 1.37 % | $ 2 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 80.34 | 2.34 % | $ 5.42 B | ||
|
Pacific Biosciences of California
PACB
|
-0.0332 | $ 1.4 | 2.94 % | $ 420 M | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
0.00787 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 454.76 | 0.25 % | $ 13.1 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
4.59 | $ 1 207.42 | 0.69 % | $ 24.9 B | ||
|
Celcuity
CELC
|
-0.0933 | $ 114.34 | -0.49 % | $ 4.51 B | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
National Research Corporation
NRC
|
-7.14 | $ 17.76 | 2.04 % | $ 398 M | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-0.401 | $ 198.56 | 0.45 % | $ 19.5 B | ||
|
OPKO Health
OPK
|
-0.902 | $ 1.2 | 0.42 % | $ 833 M |